Unraveling the mystery of preferential degeneration of midbrain neurons in neurodegenerative diseases

Project Information

oxDOPAMINE

Grant agreement ID: 948027

DOI

10.3030/948027

EC signature date 4 December 2020

Start date 1 July 2021

End date 30 June 2027

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 1 500 000,00

EU contribution

€ 1 500 000,00

Coordinated by

LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Mitochondrial Phenotypes in Parkinson's Diseases-A Focus on Human iPSC-Derived Dopaminergic Neurons.

Author(s): Leonie M. Heger; Rachel M. Wise; J. Tabitha Hees; Angelika B. Harbauer; Lena F. Burbulla
Published in: Cells, Vol 10, Iss 3436, p 3436 (2021), Issue 1, 2021, ISSN 2073-4409
Publisher: MDPI
DOI: 10.3390/cells10123436

Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson’s disease and Neurodegeneration with Brain Iron Accumulation disorders

Author(s): Wise R. M., Wagener A., Fietzek U. M., Klopstock T., Mosharov E. V., Zucca F. A., Sulzer D., Zecca L., Burbulla L. F.
Published in: Neurobiology of Disease, 2022, ISSN 0000-0000
Publisher: Elsevier
DOI: 10.1016/j.nbd.2022.105920